The Promise and Challenge of Big Data for Pharma
Harvard Business
NOVEMBER 29, 2016
It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. Historically, the pharmaceutical industry has recruited SAS programmers who have executed well-defined analyses of clinical trials in a standardized, efficient manner.
Let's personalize your content